明躍國際健康科技股份有限公司                                                   
                                                       股 東 權 益 變 動 表                                                       
                                        中華民國一○一年及一○○年一月一日至十二月三十一日                                       
                                                                                                                  單位:新台幣仟元
項    目                                普通股股本    資本公積    法定盈餘公積    未提撥保留盈餘    累積換算調整數    股東權益合計
----------------------------------------------------------------------------------------------------------------------------------
100年度                                                                                                                           
期初餘額                                 $304,558     $17,402         $18,819           $63,069          ($11,313)       $392,535 
本期損益                                        -           -               -            19,817                 -          19,817 
盈餘指撥及分配                                                                                                                    
提列法定盈餘公積                                -           -           6,186            (6,186)                -               - 
普通股現金股利                                  -           -               -           (13,705)                -         (13,705)
盈餘轉增資                                 30,456           -               -           (30,456)                -               - 
外幣財務報表換算所產生兌換差額增減              -           -               -                 -            22,391          22,391 
採權益法評價之被投資公司股權淨值增減            -         248               -                 -                 -             248 
----------------------------------------------------------------------------------------------------------------------------------
期末餘額                                 $335,014     $17,650         $25,005           $32,539           $11,078        $421,286 
==================================================================================================================================

項    目                                普通股股本    資本公積    法定盈餘公積    未提撥保留盈餘    累積換算調整數    股東權益合計
----------------------------------------------------------------------------------------------------------------------------------
101年度                                                                                                                           
期初餘額                                 $335,014     $17,650         $25,005           $32,539           $11,078        $421,286 
資本公積轉增資                                  -           -               -                 -                 -               - 
員工股票紅利                                    -           -               -                 -                 -               - 
本期損益                                        -           -               -            (1,948)                -          (1,948)
盈餘指撥及分配                                                                                                                    
提列法定盈餘公積                                -           -           1,982            (1,982)                -               - 
普通股現金股利                                  -           -               -           (10,050)                -         (10,050)
盈餘轉增資                                 20,101           -               -           (20,101)                -               - 
未按持股比例認列(長期)股權投資影響              -           -               -                 -                 -               - 
外幣財務報表換算所產生兌換差額增減              -           -               -                 -           (11,407)        (11,407)
採權益法評價之被投資公司股權淨值增減            -         238               -                 -                 -             238 
----------------------------------------------------------------------------------------------------------------------------------
期末餘額                                 $355,115     $17,888         $26,987           ($1,542)            ($329)       $398,119 
==================================================================================================================================